RT @AurelieRheumo: EULAR PtoC management of targeted therapies in pts w/ IA & Hx cancer 1) If remission, initiate ta
Tweet Content
EULAR PtoC management of targeted therapies in pts w/ IA & Hx cancer
1) If remission, initiate targeted therapy w/out delay
2) Prefer anti-cytokine bDMARDs if Hx solid cancer
3) B cell depleting therapy if Hx lymphoma
4) Use JAK inhibitors and abatacept with caution 🛑 https://t.co/cKhQVZwGh1
Show on Archive Page
On
Display in Search Results
On
PDQ
Off